Skip to Main Content
Our Commitment to Diversity

REPRESENTATIVE EXPERIENCE

Mark R. Busch

Advised Michigan-based ENDRA Life Sciences Inc. (NASDAQ: NDRA), a Nasdaq-listed medical device company developing thermoacoustic ultrasound technology, in establishing an at-the-market equity offering program with Ascendiant Capital Markets, LLC as sales agent. ENDRA may sell up to US$20.0 million of its common stock from time to time under the offering program. Ascendiant Capital Markets is a full-service boutique investment banking firm headquartered in California.
Represented Movano Inc. (NASDAQ: MOVE), a health technology company, in connection with its initial public offering of shares of common stock
Represented Exact Sciences Corporation (NASDAQ: EXAS), a molecular diagnostics company in connection with a number of underwritten public offerings of common stock and convertible notes with total gross proceeds exceeding $3 billion and a number of acquisitions with aggregate purchase prices exceeding $3 billion
Represented a manufacturer of healthcare products with respect to a number of acquisitions
Represented Energous Corporation (NASDAQ: WATT), a developer of wireless charging technology, in connection with its initial public offering and listing on NASDAQ and several follow-on secondary financing transactions
Represented FlexShopper Inc. (NASDAQ: FPAY), an online lease-to-own retailer, in connection with PIPE transaction, NASDAQ uplisting and follow-on underwritten public offering
Represented EnSync, Inc. (NYSE American: ESNC), an alternative energy company, in connection with several public and private offerings of shares of common stock, convertible preferred stock, warrants and convertible notes
Represented Cue Biopharma, Inc. (NASDAQ: CUE), an immunotherapy company, in connection with its initial public offering and listing on NASDAQ and several follow-on at-the-market financing transactions
Represented ENDRA Life Sciences Inc. (NASDAQ NDRA), an ultrasound technology company, in connection with its initial public offering and listing on NASDAQ and multiple follow-on offerings including bridge note financings, underwritten public offerings and at-the-market financing transactions
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel